{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T11:38:43Z","timestamp":1769686723877,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T00:00:00Z","timestamp":1415232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ygyno.2014.10.014","type":"journal-article","created":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T22:06:11Z","timestamp":1414101971000},"page":"474-480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Comparison of three human papillomavirus DNA assays and one mRNA assay in women with abnormal cytology"],"prefix":"10.1016","volume":"135","author":[{"given":"Matejka","family":"Rebolj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsebeth","family":"Lynge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ditte","family":"Ejegod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Preisler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Rygaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Bonde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2014.10.014_bb0005","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0010","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrclinonc.2009.167","article-title":"Primary HPV screening for cervical cancer prevention: results from European trials","volume":"12","author":"Lynge","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0015","doi-asserted-by":"crossref","first-page":"e59765","DOI":"10.1371\/journal.pone.0059765","article-title":"Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay","volume":"8","author":"Preisler","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0020","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jmoldx.2013.04.002","article-title":"Prevalence of human papillomavirus infection in unselected SurePath samples using the APTIMA HPV mRNA assay","volume":"15","author":"Rebolj","year":"2013","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0025","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.vaccine.2012.12.084","article-title":"Patterns of cervical coinfection with multiple human papilloma virus types in a screening population in Denmark","volume":"31","author":"Goldman","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0030","doi-asserted-by":"crossref","first-page":"e86835","DOI":"10.1371\/journal.pone.0086835","article-title":"Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening","volume":"9","author":"Rebolj","year":"2014","journal-title":"PLoS One"},{"issue":"7 Suppl.","key":"10.1016\/j.ygyno.2014.10.014_bb0035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1403494810393563","article-title":"The Danish Pathology Register","volume":"39","author":"Bjerregaard","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0045","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0055","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/jmv.21952","article-title":"Clinical performance of the CLART human papillomavirus 2 assay compared with the hybrid capture 2 test","volume":"83","author":"Pista","year":"2011","journal-title":"J Med Virol"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0060","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1128\/JCM.01517-13","article-title":"The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screening","volume":"51","author":"Heideman","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0065","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1128\/JCM.01674-10","article-title":"Performance of the APTIMA high-risk HPV mRNA assay in a referral population in comparison with Hybrid Capture 2 and cytology","volume":"49","author":"Clad","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0070","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.5858\/2010-0411-OAR","article-title":"Clinical performance of a human papillomavirus messenger RNA test (Aptima HPV Assay) on residual material from archived 3-year-old PreservCyt samples with low-grade squamous intraepithelial lesion","volume":"135","author":"Waldstrom","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0075","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1128\/JCM.05552-11","article-title":"Clinical validation of the cobas 4800 HPV test for cervical screening purposes","volume":"49","author":"Heideman","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1128\/JCM.05989-11","article-title":"Comparison of the cobas human papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests","volume":"50","author":"Gage","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0085","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1128\/JCM.06656-11","article-title":"Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix","volume":"50","author":"Lapierre","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0090","first-page":"CD008054","article-title":"Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions","volume":"3","author":"Arbyn","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0095","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/JCM.02147-10","article-title":"Aptima HPV E6\/E7 mRNA test is as sensitive as hybrid capture 2 assay but more specific at detecting cervical precancer and cancer","volume":"49","author":"Ratnam","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0100","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0105","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.25726","article-title":"Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study","volume":"129","author":"Monsonego","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0110","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/jmv.23590","article-title":"Use of the NucliSENS EasyQ HPV assay in the management of cervical intraepithelial neoplasia","volume":"85","author":"Oliveira","year":"2013","journal-title":"J Med Virol"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0115","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1158\/1055-9965.EPI-08-0508","article-title":"Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears","volume":"17","author":"Szarewski","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0120","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/JCM.00181-12","article-title":"Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the predictors 2 study","volume":"50","author":"Szarewski","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0125","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.ejca.2013.01.018","article-title":"Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities","volume":"49","author":"Mesher","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0130","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/jmv.21801","article-title":"Performance of the Abbott RealTime high-risk HPV test in women with abnormal cervical cytology smears","volume":"82","author":"Cuzick","year":"2010","journal-title":"J Med Virol"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0135","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1309\/AJCPZ5JY6FCVNMOT","article-title":"High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study","volume":"135","author":"Stoler","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0140","doi-asserted-by":"crossref","first-page":"144.e1","DOI":"10.1016\/j.ajog.2012.12.003","article-title":"APTIMA HPV assay performance in women with atypical squamous cells of undetermined significance cytology results","volume":"208","author":"Stoler","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jmoldx.2011.09.005","article-title":"Analytical comparison of the cobas HPV test with hybrid capture 2 for the detection of high-risk HPV genotypes","volume":"14","author":"Lindemann","year":"2012","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.7150\/ijms.5460","article-title":"Comparison of the cobas 4800 HPV test and the seeplex HPV4A ACE with the hybrid capture 2 test","volume":"10","author":"Ki","year":"2013","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0155","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/JCM.00337-12","article-title":"Clinical performances of the Abbott RealTime high risk HPV, Roche cobas HPV and hybrid capture 2 assays compared to direct sequencing and genotyping of HPV DNA","volume":"50","author":"Park","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1128\/JCM.05400-11","article-title":"Comparison of the hybrid capture 2 and cobas 4800 tests for detection of high-risk human papillomavirus in specimens collected in PreservCyt medium","volume":"50","author":"Wong","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0165","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ygyno.2010.06.011","article-title":"Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results","volume":"119","author":"Reuschenbach","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0170","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1128\/JCM.00402-09","article-title":"Evaluation of an array-based method for human papillomavirus detection and genotyping in comparison with conventional methods used in cervical cancer screening","volume":"7","author":"Garcia-Sierra","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0175","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1128\/JCM.01949-13","article-title":"Evaluation of the clinical performance of the cobas 4800 HPV test in patients referred for colposcopy","volume":"51","author":"White","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2014.10.014_bb0180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ijc.27636","article-title":"The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy","volume":"132","author":"Arbyn","year":"2013","journal-title":"Int J Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814013985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814013985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T08:29:42Z","timestamp":1538123382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814013985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0090825814013985"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.10.014","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of three human papillomavirus DNA assays and one mRNA assay in women with abnormal cytology","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}